GSA Capital Partners’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-43,385
| Closed | -$667K | – | 1825 |
|
|
2025
Q4 | $667K | Sell |
43,385
-10,017
| -19% | -$110K | 0.06% | 626 |
|
|
2025
Q3 | $530K | Buy |
+53,402
| New | +$556K | 0.04% | 803 |
|
|
2025
Q2 | – | Sell |
-21,595
| Closed | -$280K | – | 1829 |
|
|
2025
Q1 | $280K | Sell |
21,595
-52,868
| -71% | -$700K | 0.03% | 1201 |
|
|
2024
Q4 | $951K | Buy |
+74,463
| New | +$901K | 0.07% | 437 |
|
|
2024
Q2 | – | Sell |
-12,725
| Closed | -$158K | – | 1723 |
|
|
2024
Q1 | $158K | Buy |
+12,725
| New | +$166K | 0.01% | 1438 |
|
|
2023
Q1 | – | Sell |
-59,173
| Closed | -$630K | – | 1569 |
|
|
2022
Q4 | $630K | Buy |
59,173
+19,614
| +50% | +$228K | 0.08% | 453 |
|
|
2022
Q3 | $413K | Buy |
+39,559
| New | +$515K | 0.05% | 719 |
|
|
2020
Q2 | – | Sell |
-59,055
| Closed | -$208K | – | 723 |
|
|
2020
Q1 | $208K | Buy |
+59,055
| New | +$274K | 0.05% | 729 |
|
|
2019
Q3 | – | Sell |
-14,705
| Closed | -$59K | – | 1465 |
|
|
2019
Q2 | $59K | Buy |
+14,705
| New | +$85.3K | 0.01% | 1377 |
|
|
2016
Q4 | – | Sell |
-14,213
| Closed | -$149K | – | 1800 |
|
|
2016
Q3 | $149K | Buy |
+14,213
| New | +$204K | 0.01% | 1656 |
|
|
2016
Q1 | – | Sell |
-9,297
| Closed | -$225K | – | 1728 |
|
|
2015
Q4 | $225K | Buy |
+9,297
| New | +$233K | 0.01% | 1603 |
|
|
2014
Q4 | – | Sell |
-1,018
| Closed | -$15K | – | 1743 |
|
|
2014
Q3 | $15K | Buy |
+1,018
| New | +$14.7K | ﹤0.01% | 1678 |
|
Other funds holding DVAX
GSA Capital Partners's DVAX Position: Q1 2026 in Review
GSA Capital Partners sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 43,385 shares — an estimated $667K sold.
GSA Capital Partners first reported a position in DVAX in Q3 2014 and held it in 12 quarters. The position peaked at $951K in Q4 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- GSA Capital Partners reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- GSA Capital Partners sold 43,385 Dynavax Technologies shares in Q1 2026, an estimated $667K.
- GSA Capital Partners first reported a position in Dynavax Technologies in Q3 2014 and held it in 12 quarters.
- GSA Capital Partners's Dynavax Technologies position peaked at $951K in Q4 2024.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.